Search tool

Displaying 1 - 10 of 20

Infograhics shows overview of statistics of clients entering treatment for cannabis use in Europe. Most are men, in stable accomodation and self-referred. There are a range of employment statuses. Most are in stable accomodation.

Infographic: clients entering treatment for cannabis in Europe

This infographic, developed to accompany the miniguide Cannabis: health and social responses in Europe presents some key statistics on clients entering treatment with cannabis as their primary drug in the EU-27, Norway...

Most clients entering treatment for cocaine in Europe are self-referred, in outpatient settings, in stable accomodation, male, with a range of employment statuses and use several times a week

Infographic: clients entering treatment for cocaine in Europe

This infographic, developed to accompany the miniguide Stimulants: health and social responses in Europe presents some key statistics on clients entering treatment with cocaine as their primary drug, in the EU-27, Norway...

EMCDDA webinar: Drug consumption rooms in Europe

Recording of the EMCDDA webinar: Drug consumption rooms in Europe held 2 June 2022.

Most clients entering treatment for amphetamines in Europe are self-referred, in outpatient settings, in stable accomodation, male, with a range of employment statuses and use several times a week

Infographic: clients entering treatment for amphetamines in Europe

This infographic, developed to accompany the miniguide Stimulants: health and social responses in Europe presents some key statistics on clients entering treatment with amphetaminces as their primary drug, in the EU-27, Norway...

EMCDDA webinar: workplaces and drugs, issues and challenges for the future, 28 April 2022 12.00-13-30 CET

EMCDDA webinar: Workplaces and drugs – issues and challenges for the future

Recording of the EMCDDA webinar: 'Workplaces and drugs – issues and challenges for the future', held 28 April 2022.

Availability of awareness-raising responses in the workplace in Europe ranges from Finland (58.3%) to Estonia (20.9%) with an EU27 average at 36.2%.

Availability of awareness-raising responses in the workplace to prevent substance use (e.g. smoking, alcohol or drugs)

Availability of awareness-raising responses in the workplace to prevent substance use (e.g. smoking, alcohol or drugs) Data drawn from the Third European Survey on Enterprises on New and Emerging Risks...

Main behavioural techniques used in prevention interventions in high-risk neighbourhoods: evidence of effectiveness, 2019

Main behavioural techniques used in prevention interventions in high-risk neighbourhoods: evidence of effectiveness, 2019 Good evidence Unclear evidence No evidence Ratings based on expert opinion...

Countries in the west of Europe are more likely to provide take-home naloxone than in the east of Europe

Infographic. Availability of take-home naloxone programmes in Europe

This infographic, developed to accompany the miniguide Opioid-related deaths: health and social responses presents data on the availability of take-home naloxone programmes in the EU-27, Norway and Turkey (as at November 2021)...

EMCDDA webinar: Drug-related deaths in Europe, current challenges and implications for responses

Recording of the EMCDDA webinar on drug-related deaths in Europe, 8 December 2021.

Some characteristics of clients entering treatment for opioids in Europe. Most are men, self-referred, in outpatient setttings and in stable accomodation. Herion is the primary drug and injection is not the primary route of administration.

Infographic: clients entering treatment for opioids in Europe

This infographic, developed to accompany the miniguide Opioids: health and social responses in Europe presents some key statistics on clients entering treatment with opioids as their primary drug, in the EU-27, Norway...